Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
Sanofi, the company making fitusiran, says its given as a shot under the skin once a month
Low levels of glutathione (GSH) increase oxidative stress, which can be particularly damaging to the brain and may accelerate the progression of certain health conditions
Dexpanthenol (Vitamin B5) critical in the formation of Coenzyme A, a molecule that helps a large amount of enzymes function in the body and for energy production in general
DataM Intelligence has released its latest "Security Inks Market Size 2026" report, delivering comprehensive insights into market trends, growth opportunities, competitive dynamics, and regional performance